| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 546 | 33.063 | 55.842 | 187.117 | 302.791 | 369.385 | 511.932 | 642.000 |
| Total Income - EUR | - | - | 575 | 33.063 | 55.843 | 187.220 | 302.866 | 369.526 | 512.864 | 646.019 |
| Total Expenses - EUR | - | - | 2.860 | 16.566 | 34.167 | 109.277 | 178.314 | 264.880 | 341.687 | 465.109 |
| Gross Profit/Loss - EUR | - | - | -2.285 | 16.497 | 21.675 | 77.943 | 124.552 | 104.646 | 171.177 | 180.910 |
| Net Profit/Loss - EUR | - | - | -2.302 | 16.166 | 21.117 | 76.186 | 121.887 | 101.025 | 155.395 | 150.713 |
| Employees | - | - | 0 | 1 | 1 | 3 | 5 | 6 | 6 | 8 |
Check the financial reports for the company - Neuro Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.226 | 1.075 | 5.562 | 33.048 | 63.929 | 53.432 | 80.855 |
| Current Assets | - | - | 605 | 18.986 | 42.561 | 90.355 | 189.102 | 254.819 | 439.681 | 364.785 |
| Inventories | - | - | 0 | 0 | 304 | 196 | 162 | 0 | 122 | 37 |
| Receivables | - | - | 0 | 0 | 7.415 | 16.598 | 31.209 | 23.606 | 76.491 | 5.959 |
| Cash | - | - | 605 | 18.986 | 34.843 | 73.561 | 157.731 | 231.214 | 363.068 | 358.788 |
| Shareholders Funds | - | - | -2.258 | 13.949 | 34.796 | 89.648 | 209.547 | 101.074 | 256.162 | 150.761 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.863 | 6.263 | 8.840 | 6.268 | 12.603 | 217.674 | 236.951 | 294.878 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Therapy Srl